Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The disappearance of gastric metastasis and liver metastasis in non-small cell lung adenocarcinoma is due to osimertinib.

Journal of cancer research and clinical oncology - 1 Nov 2023

Wang Yun, Yan Chao, Zhang Chuantao, Yu Enhao, Wang Kai, Liu Xiangyong, Yu Jie, Zhou Chunyang, Yang Aijie

Abstract excerpt

PURPOSE: Gastric metastasis of lung cancer is rare, and the cases of disappearance of gastric metastasis and liver metastasis caused by oxitinib treatment have not been reported. METHODS: A 47-year-old male patient with no history of diabetes, hypertension or smoking presented with chest discomfort after eating. At the time of consultation, the diagnosis of adenocarcinoma of the right lower lobe of the lung with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Adenocarcinoma of Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Aniline Compounds

Share to Liver Neoplasms

Share to Protein Kinase Inhibitors

Share to Quality of Life

Share to Stomach

Source

Open in PubMed Open full text

Identifiers

PMID: 37695388
DOI: 10.1007/s00432-023-05386-7
PMCID: PMC10620294

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The disappearance of gastric metastasis and liver metastasis in non-small cell lung adenocarcinoma is due to osimertinib.PMID 37695388Read ↗

Gastric Metastasis and Transformation of Primary Lung Adenocarcinoma to Small Cell Cancer After Acquired Resistance to EGFR-TkIs: A Case ReportSemantic proximity Read ↗

Complete response in a lung adenocarcinoma with pleural metastases initially treated with gefitinib and switched to osimertinib after cerebral oligo-progression with unknown T790M mutation: a case report and review of literature.Semantic proximity Read ↗

Aumolertinib effectively reduces clinical symptoms of an EGFR L858R-mutant non-small cell lung cancer case coupled with osimertinib-induced severe thrombocytopenia: a case report.Semantic proximity Read ↗

[A Case of Multiple Brain Metastases after Surgery for Lung Cancer Successfully Treated with Osimertinib].Semantic proximity Read ↗

Metastatic Lung Tumors from Colorectal Cancer with EGFR Mutations That Responded to Osimertinib.Semantic proximity Read ↗

Clinical efficacy of osimertinib in EGFR-mutant non-small cell lung cancer with distant metastasisSemantic proximity Read ↗

Analysis of non-small cell lung cancer with miliary lung metastasis in patients harboring epidermal growth factor receptor mutations.Semantic proximity Read ↗

Osimertinib showed efficacy on contralateral multiple ground-glass nodules after segmentectomy for lung adenocarcinoma harboring primary EGFR-T790M mutation: a case report and review of the literature.Semantic proximity Read ↗

A novel osimertinib-resistant human lung adenocarcinoma cell line harbouring mutant EGFR and activated IGF1R.Semantic proximity Read ↗

Efficacy of 3rd generation TKI in patients with EGFR mutation lung adenocarcinoma with bone metastases: A review of 3 case reports and literature.Semantic proximity Read ↗

Clinical efficacy of osimertinib in EGFR-mutant non-small cell lung cancer with distant metastasis.Semantic proximity Read ↗

Nasogastric administration of osimertinib suspension for an epidermal growth factor receptor-mutated lung cancer causing an esophageal stricture: case report.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.